Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 250


Three-Month Randomized Clinical Trial of Nasal Calcitonin in Adults with X-linked Hypophosphatemia.

Sullivan R, Abraham A, Simpson C, Olear E, Carpenter T, Deng Y, Chen C, Insogna KL.

Calcif Tissue Int. 2018 Jun;102(6):666-670. doi: 10.1007/s00223-017-0382-0. Epub 2018 Jan 30.


Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study.

Lu C, Chen Y, Zhang B, Chen Y, Bai F, Chen D.

Clin Interv Aging. 2017 Oct 12;12:1717-1723. doi: 10.2147/CIA.S140900. eCollection 2017.


A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.

Henriksen K, Byrjalsen I, Andersen JR, Bihlet AR, Russo LA, Alexandersen P, Valter I, Qvist P, Lau E, Riis BJ, Christiansen C, Karsdal MA; SMC021 investigators.

Bone. 2016 Oct;91:122-9. doi: 10.1016/j.bone.2016.07.019. Epub 2016 Jul 25.


[Postmenopausal osteoporosis treated with acupoint injection of salmon calcitonin:a randomized controlled trial].

Zhou Z, Wang N, Ding C, Zhou X, Zhou J.

Zhongguo Zhen Jiu. 2016 Jul 12;36(7):705-708. doi: 10.13703/j.0255-2930.2016.07.008. Chinese.


Can calcitonin nasal spray reduce the risk of recurrence of central giant cell granuloma of the jaws? A double-blind clinical trial.

Tabrizi R, Fardisi S, Zamiri B, Amanpour S, Karagah T.

Int J Oral Maxillofac Surg. 2016 Jun;45(6):756-9. doi: 10.1016/j.ijom.2016.02.016. Epub 2016 Mar 15.


[Effects of different treatments on patients with osteoporotic fracture after percutaneous kyphoplasty].

Wang XF, Xu B, Ye XY, Yang YY, Wang GH.

Zhongguo Gu Shang. 2015 Jun;28(6):512-6. Chinese.


Analgesic effect of nasal salmon calcitonin during the early post-fracture period of the distal radius fracture.

Karponis A, Rizou S, Pallis D, Zafeiris CP, Georgiou DF, Galanos A, Giannoulis F, Lyritis GP.

J Musculoskelet Neuronal Interact. 2015 Jun;15(2):186-9.


Effects of salmon calcitonin treatment on serum and synovial fluid bone formation and resorption markers in osteoporosis patients.

Atbinici H, Sipahioğlu S, Aksoy N, Baykara İ, Işıkan UE.

Acta Orthop Traumatol Turc. 2015;49(2):160-5. doi: 10.3944/AOTT.2015.3035.


Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.

Karsdal MA, Byrjalsen I, Alexandersen P, Bihlet A, Andersen JR, Riis BJ, Bay-Jensen AC, Christiansen C; CSMC021C2301/2 investigators.

Osteoarthritis Cartilage. 2015 Apr;23(4):532-43. doi: 10.1016/j.joca.2014.12.019. Epub 2015 Jan 9.


OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA.

Karsdal MA, Bihlet A, Byrjalsen I, Alexandersen P, Ladel C, Michaels M, Andersen JR, Riis BJ, Kraus V, Bay-Jensen AC, Christiansen C.

Osteoarthritis Cartilage. 2015 Apr;23(4):550-8. doi: 10.1016/j.joca.2014.12.024. Epub 2015 Jan 8.


Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.

Rizzoli R, Sigaud A, Azria M, Herrmann FR.

Osteoporos Int. 2015 Jan;26(1):383-93. doi: 10.1007/s00198-014-2937-5. Epub 2014 Oct 22.


Salmon calcitonin in the treatment of elderly women with type 2 diabetes complicated with osteoporosis.

Dexue L, Yueyue Z.

Pak J Pharm Sci. 2014 Nov;27(6 Suppl):2079-81.


Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer.

Liu P, Yang DQ, Xie F, Zhou B, Liu M.

Genet Mol Res. 2014 Jul 24;13(3):5285-91. doi: 10.4238/2014.July.24.7.


Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial.

Binkley N, Bone H, Gilligan JP, Krause DS.

Osteoporos Int. 2014 Nov;25(11):2649-56. doi: 10.1007/s00198-014-2796-0. Epub 2014 Jul 16.


Inhalation therapy of calcitonin relieves osteoarthritis of the knee.

Armagan O, Serin DK, Calisir C, Dokumacioglu A, Ozgen M, Oner S, Alatas O.

J Korean Med Sci. 2012 Nov;27(11):1405-10. doi: 10.3346/jkms.2012.27.11.1405. Epub 2012 Oct 30.


A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.

Binkley N, Bolognese M, Sidorowicz-Bialynicka A, Vally T, Trout R, Miller C, Buben CE, Gilligan JP, Krause DS; Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators.

J Bone Miner Res. 2012 Aug;27(8):1821-9. doi: 10.1002/jbmr.1602.


Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial.

Pappa HM, Saslowsky TM, Filip-Dhima R, DiFabio D, Hassani Lahsinoui H, Akkad A, Grand RJ, Gordon CM.

Am J Gastroenterol. 2011 Aug;106(8):1527-43. doi: 10.1038/ajg.2011.129. Epub 2011 Apr 26.


Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials.

Karsdal MA, Henriksen K, Bay-Jensen AC, Molloy B, Arnold M, John MR, Byrjalsen I, Azria M, Riis BJ, Qvist P, Christiansen C.

J Clin Pharmacol. 2011 Apr;51(4):460-71. doi: 10.1177/0091270010372625. Epub 2010 Jul 21. Review.


Supplemental Content

Loading ...
Support Center